UK approves first protein-based vaccine

RT

February 3, 2022

On Thursday, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) approved Novavax’s vaccine as the country’s fifth shot to protect against Covid-19. Those aged 18 and over can receive the shot.

The shot, called Nuvaxovid, is the first protein-based vaccine approved in the UK for use against Covid-19. It is administered in a two-dose-regimen and has demonstrated efficacy levels above 90%. 

Read more…